Clinical Trial Update: Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (NCT02077621) evaluating PG2 Injection to improve fatigue after palliative abdominal cancer surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• PG2 Injection (PG2)

Snippet

Sponsor: PhytoHealth Corporation | Conditions: Cancer, Surgery | Phase 2 | Status: WITHDRAWN